These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37822880)

  • 1. METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway.
    Wang Y; Hong Z; Song J; Zhong P; Lin L
    Front Pharmacol; 2023; 14():1257410. PubMed ID: 37822880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.
    Li H; Wang C; Lan L; Yan L; Li W; Evans I; Ruiz EJ; Su Q; Zhao G; Wu W; Zhang H; Zhou Z; Hu Z; Chen W; Oliveira JM; Behrens A; Reis RL; Zhang C
    Cell Mol Life Sci; 2022 Feb; 79(3):135. PubMed ID: 35179655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
    Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
    FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin F
    Wang YJ; Xie XL; Liu HQ; Tian H; Jiang XY; Zhang JN; Chen SX; Liu T; Wang SL; Zhou X; Jin XX; Liu SM; Jiang HQ
    World J Gastroenterol; 2023 Oct; 29(39):5452-5470. PubMed ID: 37900995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Associated Macrophages Promote Oxaliplatin Resistance
    Lan H; Liu Y; Liu J; Wang X; Guan Z; Du J; Jin K
    Mol Pharm; 2021 Mar; 18(3):1026-1037. PubMed ID: 33555197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 Promotes the Proliferation and Mobility of Gastric Cancer Cells.
    Lin S; Liu J; Jiang W; Wang P; Sun C; Wang X; Chen Y; Wang H
    Open Med (Wars); 2019; 14():25-31. PubMed ID: 30886897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin and Gedatolisib (PKI-587) Co-Loaded Hollow Polydopamine Nano-Shells with Simultaneous Upstream and Downstream Action to Re-Sensitize Drugs-Resistant Hepatocellular Carcinoma to Chemotherapy.
    Zhang YC; Wu CG; Li AM; Liang Y; Ma D; Tang XL
    J Biomed Nanotechnol; 2021 Jan; 17(1):18-36. PubMed ID: 33653494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LACTB induced apoptosis of oxaliplatin-resistant gastric cancer through regulating autophagy-mediated mitochondrial apoptosis pathway.
    Yang F; Yan Z; Nie W; Cheng X; Liu Z; Wang W; Shao C; Fu G; Yu Y
    Am J Transl Res; 2021; 13(2):601-616. PubMed ID: 33594312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer.
    Song W; Qian Y; Zhang MH; Wang H; Wen X; Yang XZ; Dai WJ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3049-3061. PubMed ID: 32271422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3/cyclin D1 pathway.
    Meng H; Li J; Sun H; Lin Y; Xu H; Zhang N
    Drug Dev Res; 2023 Sep; 84(6):1325-1334. PubMed ID: 37421203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
    Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
    World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway.
    Yang DD; Chen ZH; Yu K; Lu JH; Wu QN; Wang Y; Ju HQ; Xu RH; Liu ZX; Zeng ZL
    Front Oncol; 2020; 10():115. PubMed ID: 32175271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ_0032821 contributes to oxaliplatin (OXA) resistance of gastric cancer cells by regulating SOX9 via miR-515-5p.
    Zhong Y; Wang D; Ding Y; Tian G; Jiang B
    Biotechnol Lett; 2021 Feb; 43(2):339-351. PubMed ID: 33123829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway.
    Li H; Wang C; Lan L; Wu W; Evans I; Ruiz EJ; Yan L; Zhou Z; Oliveira JM; Reis RL; Hu Z; Chen W; Behrens A; He Y; Zhang C
    Front Cell Dev Biol; 2021; 9():719192. PubMed ID: 34497808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic potential of METTL3 expression in patients with gastric cancer.
    Okugawa Y; Toiyama Y; Yin C; Ruiya M; Goel A; Ichikawa T; Imaoka H; Kitajima T; Shimura T; Kawamura M; Yasuda H; Fujikawa H; Yokoe T; Mochiki I; Ohi M; Nakatani K
    Oncol Lett; 2023 Feb; 25(2):64. PubMed ID: 36644137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRC8A promotes the initial development of oxaliplatin resistance in colon cancer cells.
    Zhang H; Jing Z; Liu R; Shada Y; Shria S; Cui S; Ren Y; Wei Y; Li L; Peng S
    Heliyon; 2023 Jun; 9(6):e16872. PubMed ID: 37313175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circLRCH3 promotes oxaliplatin resistance in gastric cancer through the modulation of the miR-383-5p/FGF7 axis.
    Xiang C; Li R; Qiu H; Zuo E; Zhang Y; Shan L; Cheng X
    Histol Histopathol; 2023 Jun; 38(6):647-658. PubMed ID: 35920365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
    Hsu HH; Chen MC; Baskaran R; Lin YM; Day CH; Lin YJ; Tu CC; Vijaya Padma V; Kuo WW; Huang CY
    J Cell Physiol; 2018 Jul; 233(7):5458-5467. PubMed ID: 29247488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.